Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 38,726 shares at $13.76 ($530K) on 2016-06-21, disclosed to the SEC on 2016-06-22.
Open-market purchase of $530k FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.70 | 3,343 | $46K | 8.6% |
| 2 | $13.98 | 3,435 | $48K | 9.1% |
| 3 | $13.62 | 13,222 | $180K | 34.0% |
| 4 | $13.62 | 13,222 | $180K | 34.0% |
| 5 | $13.65 | 504 | $7K | 1.3% |
| 6 | $13.71 | 400 |
| $5K |
| 1.0% |
| 7 | $13.76 | 4,600 | $63K | 12.0% |
| Total | $13.68 avg | 38,726 | $530K | 100% |
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLXN | BUY | 2019-08-09 | $21K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |